Estudo de caso-controle | Em crianças de 5 a 11 anos de idade, a vacina da Pfizer mostrou efetividade de 68% contra internação causada pela variante Ômicron.

BNT162b2 Protection against the Omicron Variant in Children and Adolescents – New England Journal of Medicine

Comentário: COVID vaccination of children age 5-11 cut omicron hospitalizations by 68% – Children’s Hospital Boston

Conteúdo relacionado: [Preprint] Study shows significantly reduced effectiveness of the Pfizer vaccine in children 5 to 11 after the emergency of the Omicron variant.

Comentário no Twitter

BNT162b2 vaccination reduced the risk of omicron-associated hospitalization by two thirds among children 5 to 11 years of age. https://t.co/mQcchQqbtH pic.twitter.com/Qzy8qKg1wC

— NEJM (@NEJM) March 30, 2022